Skip to content

Drug interactions

Brentuximab + Carbamazepine

Severity: Minor

Brentuximab and Carbamazepine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Carbamazepine is a strong CYP3A4 inducer and may lower exposure to MMAE, the cytotoxic component released from brentuximab vedotin. Reduced MMAE exposure might diminish efficacy, though the effect is modest in labeling data.

What this interaction means in plain words

Brentuximab and Carbamazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Brentuximab belongs to Oncology; Carbamazepine belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

CYP3A4 induction increases metabolism of MMAE.

What to do

No dose adjustment is required; monitor response to brentuximab. Consider a non-inducing anticonvulsant where practical.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab and Carbamazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab with Carbamazepine?

MediHelp rates the interaction as minor. Brentuximab and Carbamazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Carbamazepine is a strong CYP3A4 inducer and may lower exposure to MMAE, the cytotoxic component released from brentuximab vedotin. Reduced MMAE exposure might diminish efficacy, though the effect is modest in labeling data.

How serious is the interaction between Brentuximab and Carbamazepine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is required; monitor response to brentuximab. Consider a non-inducing anticonvulsant where practical.

What other medicines interact with Brentuximab?

MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in